Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome accounting for half of heart failure cases. Although natriuretic peptides are the most accepted and extensively used biomarkers for heart failure, their diagnostic accuracy for HFpEF remains debatable. Here, w...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.15324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850059624517992448 |
|---|---|
| author | Reza Parvan Natale Rolim Andreas B. Gevaert Alessandro Cataliotti Emeline M. vanCraenenbroeck Volker Adams Ulrik Wisløff Gustavo Jose Justo Silva the OptimEx Study Group |
| author_facet | Reza Parvan Natale Rolim Andreas B. Gevaert Alessandro Cataliotti Emeline M. vanCraenenbroeck Volker Adams Ulrik Wisløff Gustavo Jose Justo Silva the OptimEx Study Group |
| author_sort | Reza Parvan |
| collection | DOAJ |
| description | Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome accounting for half of heart failure cases. Although natriuretic peptides are the most accepted and extensively used biomarkers for heart failure, their diagnostic accuracy for HFpEF remains debatable. Here, we aimed to identify a panel of circulating microRNAs (miRNAs) as potential novel biomarkers for diagnosis of HFpEF in a preclinical model, subsequently validated in human HFpEF patients. Methods and results In a female hypertension‐induced HFpEF model [Dahl/Salt Sensitive (DSS) rats], circulating miRNA levels were screened in the plasma via real‐time quantitative polymerase chain reaction. DSS rats exhibited HFpEF features as indicated by diastolic dysfunction and adverse cardiac remodelling when fed a high‐salt (8%) diet (n = 11) compared with a low‐salt (0.3%) diet (n = 15). A panel of four circulating miRNAs (rno‐let‐7b‐5p, rno‐let‐7e‐5p, rno‐miR‐21‐5p and rno‐miR‐140‐3p) were found significantly altered in the DSS plasma. Clinical performance of miRNA expression analysis was assessed in publicly available datasets of human heart failure patients, including assessment of discrimination of different categories of heart failure [GSE53437; control = 30, heart failure with reduced ejection fraction (HFrEF) = 41, HFpEF = 19] and gender differences (GSE104150; female = 6, male = 10). The miRNA panel significantly discriminated HFpEF patients from healthy individuals and HFrEF patients. We also found significant downregulation of let‐7b‐5p and miR‐21‐5p in females compared with males, regardless of health status. Conclusions A panel of four circulating miRNAs was differently expressed in female HFpEF rats and significantly discriminated HFpEF patients from healthy individuals and HFrEF patients. This cross‐species and bench‐to‐bedside approach demonstrates the potential of miRNA‐based panels for HFpEF diagnosis. |
| format | Article |
| id | doaj-art-ffc1cce385ca4da9b8e0eeea2cdb4ec2 |
| institution | DOAJ |
| issn | 2055-5822 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | ESC Heart Failure |
| spelling | doaj-art-ffc1cce385ca4da9b8e0eeea2cdb4ec22025-08-20T02:50:51ZengWileyESC Heart Failure2055-58222025-08-011243028304110.1002/ehf2.15324Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settingsReza Parvan0Natale Rolim1Andreas B. Gevaert2Alessandro Cataliotti3Emeline M. vanCraenenbroeck4Volker Adams5Ulrik Wisløff6Gustavo Jose Justo Silva7the OptimEx Study GroupInstitute for Experimental Medical Research Oslo University Hospital and University of Oslo Oslo NorwayDepartment of Circulation and Medical Imaging Norwegian University of Science and Technology Trondheim NorwayResearch Group Cardiovascular Diseases, GENCOR Department University of Antwerp Antwerp BelgiumInstitute for Experimental Medical Research Oslo University Hospital and University of Oslo Oslo NorwayResearch Group Cardiovascular Diseases, GENCOR Department University of Antwerp Antwerp BelgiumLaboratory of Molecular and Experimental Cardiology TU Dresden, Heart Center Dresden Dresden GermanyDepartment of Circulation and Medical Imaging Norwegian University of Science and Technology Trondheim NorwayDepartment of Molecular Medicine, Institute of Basic Medical Sciences University of Oslo Oslo NorwayAbstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome accounting for half of heart failure cases. Although natriuretic peptides are the most accepted and extensively used biomarkers for heart failure, their diagnostic accuracy for HFpEF remains debatable. Here, we aimed to identify a panel of circulating microRNAs (miRNAs) as potential novel biomarkers for diagnosis of HFpEF in a preclinical model, subsequently validated in human HFpEF patients. Methods and results In a female hypertension‐induced HFpEF model [Dahl/Salt Sensitive (DSS) rats], circulating miRNA levels were screened in the plasma via real‐time quantitative polymerase chain reaction. DSS rats exhibited HFpEF features as indicated by diastolic dysfunction and adverse cardiac remodelling when fed a high‐salt (8%) diet (n = 11) compared with a low‐salt (0.3%) diet (n = 15). A panel of four circulating miRNAs (rno‐let‐7b‐5p, rno‐let‐7e‐5p, rno‐miR‐21‐5p and rno‐miR‐140‐3p) were found significantly altered in the DSS plasma. Clinical performance of miRNA expression analysis was assessed in publicly available datasets of human heart failure patients, including assessment of discrimination of different categories of heart failure [GSE53437; control = 30, heart failure with reduced ejection fraction (HFrEF) = 41, HFpEF = 19] and gender differences (GSE104150; female = 6, male = 10). The miRNA panel significantly discriminated HFpEF patients from healthy individuals and HFrEF patients. We also found significant downregulation of let‐7b‐5p and miR‐21‐5p in females compared with males, regardless of health status. Conclusions A panel of four circulating miRNAs was differently expressed in female HFpEF rats and significantly discriminated HFpEF patients from healthy individuals and HFrEF patients. This cross‐species and bench‐to‐bedside approach demonstrates the potential of miRNA‐based panels for HFpEF diagnosis.https://doi.org/10.1002/ehf2.15324cross‐species validationdiagnosisHFpEFHFrEFmicroRNA |
| spellingShingle | Reza Parvan Natale Rolim Andreas B. Gevaert Alessandro Cataliotti Emeline M. vanCraenenbroeck Volker Adams Ulrik Wisløff Gustavo Jose Justo Silva the OptimEx Study Group Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings ESC Heart Failure cross‐species validation diagnosis HFpEF HFrEF microRNA |
| title | Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings |
| title_full | Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings |
| title_fullStr | Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings |
| title_full_unstemmed | Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings |
| title_short | Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings |
| title_sort | multi microrna diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings |
| topic | cross‐species validation diagnosis HFpEF HFrEF microRNA |
| url | https://doi.org/10.1002/ehf2.15324 |
| work_keys_str_mv | AT rezaparvan multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings AT natalerolim multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings AT andreasbgevaert multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings AT alessandrocataliotti multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings AT emelinemvancraenenbroeck multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings AT volkeradams multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings AT ulrikwisløff multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings AT gustavojosejustosilva multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings AT theoptimexstudygroup multimicrornadiagnosticpanelforheartfailurewithpreservedejectionfractioninpreclinicalandclinicalsettings |